SANOFI AVENTIS US FDA Approval NDA 020784

NDA 020784

SANOFI AVENTIS US

FDA Drug Application

Application #020784

Documents

Letter2004-04-20
Review2007-07-03

Application Sponsors

NDA 020784SANOFI AVENTIS US

Marketing Status

Discontinued001

Application Products

001SPRAY, METERED;NASAL0.055MG/SPRAY0NASACORT HFATRIAMCINOLONE ACETONIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2004-04-07STANDARD

CDER Filings

SANOFI AVENTIS US
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20784
            [companyName] => SANOFI AVENTIS US
            [docInserts] => ["",""]
            [products] => [{"drugName":"NASACORT HFA","activeIngredients":"TRIAMCINOLONE ACETONIDE","strength":"0.055MG\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NASACORT HFA","submission":"TRIAMCINOLONE ACETONIDE","actionType":"0.055MG\/SPRAY","submissionClassification":"SPRAY, METERED;NASAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.